{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:59:13Z","timestamp":1793159953753,"version":"4.5.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004593","name":"Universidad Aut\u00f3noma de Madrid","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Quality-of-life (QoL) measures are key for monitoring health of patients with Parkinson\u2019s disease (PD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This systematic review aimed to gather evidence on the psychometric properties of available patient-reported outcomes measures (PROMs) for assessing QoL in people with PD (PwPD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A search of PROMs was conducted in PubMed (MEDLINE), Embase, Scopus, Web of Science, PSICDOC, and \u2018gray literature\u2019 (April 2024, PROSPERO-ID: CRD42024526458). After screening and data extraction, in a two-phase procedure conducted by independent reviewers, a critical assessment of feasibility, validity (content, structural, known-group, and criterion) and reliability (internal consistency, test\u2013retest, and measurement error) was conducted based on the COSMIN criteria for good psychometric properties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The search identified 83 eligible studies from which 29 PROMs were gathered (15 PD-specific and 14 generic\/unspecific PROMs validated for PD). All PROMs proved their feasibility and included common dimensions between them, suggesting adequate content validity. Among the 29 PROMs, 17 reported data on structural validity (58.6%), 20 on known-group validity (69.0%), 25 on criterion validity (86.2%), 23 on internal consistency (79.3%), 11 on test\u2013retest validity (37.9%), and 4 on measurement error (13.8%). According to the COSMIN criteria, 6 PROMs have the potential to be the most suitable QoL measure for PwPD: PDQ-39, PDQ-8, PDQL, PDQUALIF, PIMS, and Neuro-QOL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Several PROMs are feasible, valid, and reliable for measuring QoL in PwPD. However, further research ensuring their psychometric properties and cross-cultural adaptations are needed to recommend their use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-025-13348-x","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T17:53:47Z","timestamp":1756403627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Quality of life measures in Parkinson\u2019s disease: a systematic literature review of patient-reported outcomes measures (PROMs) and their psychometric properties"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2501-3049","authenticated-orcid":false,"given":"Alberto","family":"de la Cuadra-Grande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Rejas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8743-6653","authenticated-orcid":false,"given":"Miguel \u00c1ngel","family":"Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7004-0217","authenticated-orcid":false,"given":"Manuel","family":"Monroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"13348_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","volume":"103","author":"SG Reich","year":"2019","unstructured":"Reich SG, Savitt JM (2019) Parkinson\u2019s disease. Med Clin North Am 103:337\u2013350. https:\/\/doi.org\/10.1016\/j.mcna.2018.10.014","journal-title":"Med Clin North Am"},{"key":"13348_CR2","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"MT Hayes","year":"2019","unstructured":"Hayes MT (2019) Parkinson\u2019s disease and parkinsonism. Am J Med 132:802\u2013807. https:\/\/doi.org\/10.1016\/j.amjmed.2019.03.001","journal-title":"Am J Med"},{"key":"13348_CR3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. JAMA 323:548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"key":"13348_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2024.100425","volume":"79","author":"T de la Rosa","year":"2024","unstructured":"de la Rosa T, Scorza FA (2024) Contextualizing stigma in Parkinson\u2019s disease research. Clinics 79:100425. https:\/\/doi.org\/10.1016\/j.clinsp.2024.100425","journal-title":"Clinics"},{"key":"13348_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2021-100653","volume":"35","author":"SS Islam","year":"2022","unstructured":"Islam SS, Neargarder S, Kinger SB et al (2022) Perceived stigma and quality of life in Parkinson\u2019s disease with additional health conditions. Gen Psychiatr 35:e100653. https:\/\/doi.org\/10.1136\/gpsych-2021-100653","journal-title":"Gen Psychiatr"},{"key":"13348_CR6","first-page":"S168","volume":"18","author":"DF Boland","year":"2012","unstructured":"Boland DF, Stacy M (2012) The economic and quality of life burden associated with Parkinson\u2019s disease: a focus on symptoms. Am J Manag Care 18:S168-175","journal-title":"Am J Manag Care"},{"key":"13348_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/bs.irn.2017.05.023","volume":"133","author":"P Barone","year":"2017","unstructured":"Barone P, Erro R, Picillo M (2017) Quality of life and nonmotor symptoms in Parkinson\u2019s disease. Int Rev Neurobiol 133:499\u2013516. https:\/\/doi.org\/10.1016\/bs.irn.2017.05.023","journal-title":"Int Rev Neurobiol"},{"key":"13348_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000479031","volume":"48","author":"K Rajiah","year":"2017","unstructured":"Rajiah K, Maharajan MK, Yeen SJ, Lew S (2017) Quality of life and caregivers\u2019 burden of Parkinson\u2019s disease. Neuroepidemiology 48:131\u2013137. https:\/\/doi.org\/10.1159\/000479031","journal-title":"Neuroepidemiology"},{"key":"13348_CR9","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/biom11040612","volume":"11","author":"FC Church","year":"2021","unstructured":"Church FC (2021) Treatment options for motor and non-motor symptoms of Parkinson\u2019s disease. Biomolecules 11:612. https:\/\/doi.org\/10.3390\/biom11040612","journal-title":"Biomolecules"},{"key":"13348_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1586\/14737167.4.4.413","volume":"4","author":"RA Cummins","year":"2004","unstructured":"Cummins RA, Lau AL, Stokes M (2004) HRQOL and subjective well-being: noncomplementary forms of outcome measurement. Expert Rev Pharmacoecon Outcomes Res 4:413\u2013420. https:\/\/doi.org\/10.1586\/14737167.4.4.413","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"13348_CR11","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/hex.13254","volume":"24","author":"K Churruca","year":"2021","unstructured":"Churruca K, Pomare C, Ellis LA et al (2021) Patient-reported outcome measures (PROMs): a review of generic and condition-specific measures and a discussion of trends and issues. Health Expect 24:1015\u20131024. https:\/\/doi.org\/10.1111\/hex.13254","journal-title":"Health Expect"},{"key":"13348_CR12","unstructured":"Damiano AM, Snyder C, Strausser B, Willian MK A review of health-related quality-of-life concepts and measures for Parkinson\u2019s disease"},{"key":"13348_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1179\/174239505X44835","volume":"1","author":"C Heffernan","year":"2005","unstructured":"Heffernan C, Jenkinson C (2005) Measuring outcomes for neurological disorders: a review of disease-specific health status instruments for three degenerative neurological conditions. Chron Ill 1:131\u2013142. https:\/\/doi.org\/10.1179\/174239505X44835","journal-title":"Chron Ill"},{"key":"13348_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1586\/14737167.8.4.401","volume":"8","author":"P Martinez-Martin","year":"2008","unstructured":"Martinez-Martin P, Rodriguez-Blazquez C, Frades-Payo B (2008) Specific patient-reported outcome measures for Parkinson\u2019s disease: analysis and applications. Expert Rev Pharmacoecon Outcomes Res 8:401\u2013418. https:\/\/doi.org\/10.1586\/14737167.8.4.401","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"13348_CR15","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1002\/mds.23834","volume":"26","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P, Jeukens-Visser M, Lyons KE et al (2011) Health-related quality-of-life scales in Parkinson\u2019s disease: critique and recommendations. Mov Disord 26:2371\u20132380. https:\/\/doi.org\/10.1002\/mds.23834","journal-title":"Mov Disord"},{"key":"13348_CR16","first-page":"375","volume":"5","author":"JA Opara","year":"2012","unstructured":"Opara JA, Brola W, Leonardi M, B\u0142aszczyk B (2012) Quality of life in Parkinson\u2019s disease. J Med Life 5:375\u2013381","journal-title":"J Med Life"},{"key":"13348_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mds.25571","volume":"29","author":"R Dodel","year":"2014","unstructured":"Dodel R, J\u00f6nsson B, Reese JP et al (2014) Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson\u2019s disease. Mov Disord 29:169\u2013176. https:\/\/doi.org\/10.1002\/mds.25571","journal-title":"Mov Disord"},{"key":"13348_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11136-016-1428-x","volume":"26","author":"Y Xin","year":"2017","unstructured":"Xin Y, McIntosh E (2017) Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson\u2019s: a systematic review. Qual Life Res 26:1\u201323. https:\/\/doi.org\/10.1007\/s11136-016-1428-x","journal-title":"Qual Life Res"},{"key":"13348_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/14737167.2021.1841638","volume":"21","author":"A Berardi","year":"2021","unstructured":"Berardi A, Regoli E, Tofani M et al (2021) Tools to assess the quality of life in patients with Parkinson\u2019s disease: a systematic review. Expert Rev Pharmacoecon Outcomes Res 21:55\u201368. https:\/\/doi.org\/10.1080\/14737167.2021.1841638","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"13348_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/cns.13549","volume":"27","author":"N Zhao","year":"2021","unstructured":"Zhao N, Yang Y, Zhang L et al (2021) Quality of life in Parkinson\u2019s disease: a systematic review and meta-analysis of comparative studies. CNS Neurosci Ther 27:270\u2013279. https:\/\/doi.org\/10.1111\/cns.13549","journal-title":"CNS Neurosci Ther"},{"key":"13348_CR21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/mdc3.14063","volume":"11","author":"M van Munster","year":"2024","unstructured":"van Munster M, Pedrosa AJ, K\u00fcnkler C, Pedrosa DJ (2024) The quality in quality of life in Parkinson\u2019s disease: a qualitative meta-synthesis. Mov Disord Clin Pract 11:761\u2013769. https:\/\/doi.org\/10.1002\/mdc3.14063","journal-title":"Mov Disord Clin Pract"},{"issue":"Suppl 2","key":"13348_CR22","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1111\/j.1524-4733.2007.00272.x","volume":"10","author":"MH Frost","year":"2007","unstructured":"Frost MH, Reeve BB, Liepa AM et al (2007) What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health 10(Suppl 2):S94\u2013S105. https:\/\/doi.org\/10.1111\/j.1524-4733.2007.00272.x","journal-title":"Value Health"},{"key":"13348_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"13348_CR24","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s11136-018-1798-3","volume":"27","author":"CAC Prinsen","year":"2018","unstructured":"Prinsen CAC, Mokkink LB, Bouter LM et al (2018) COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res 27:1147\u20131157. https:\/\/doi.org\/10.1007\/s11136-018-1798-3","journal-title":"Qual Life Res"},{"key":"13348_CR25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11136-010-9606-8","volume":"19","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, Terwee CB, Patrick DL et al (2010) The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 19:539\u2013549. https:\/\/doi.org\/10.1007\/s11136-010-9606-8","journal-title":"Qual Life Res"},{"key":"13348_CR26","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s11136-017-1765-4","volume":"27","author":"LB Mokkink","year":"2018","unstructured":"Mokkink LB, De Vet HCW, Prinsen CAC et al (2018) COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res 27:1171\u20131179. https:\/\/doi.org\/10.1007\/s11136-017-1765-4","journal-title":"Qual Life Res"},{"key":"13348_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12874-020-01179-5","volume":"20","author":"LB Mokkink","year":"2020","unstructured":"Mokkink LB, Boers M, Van Der Vleuten CPM et al (2020) COSMIN risk of bias tool to assess the quality of studies on reliability or measurement error of outcome measurement instruments: a Delphi study. BMC Med Res Methodol 20:293. https:\/\/doi.org\/10.1186\/s12874-020-01179-5","journal-title":"BMC Med Res Methodol"},{"key":"13348_CR28","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","volume":"63","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, Terwee CB, Patrick DL et al (2010) The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 63:737\u2013745. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.02.006","journal-title":"J Clin Epidemiol"},{"key":"13348_CR29","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1097\/01.mlr.0000245426.10853.30","volume":"44","author":"RF DeVellis","year":"2006","unstructured":"DeVellis RF (2006) Classical test theory. Med Care 44:S50-59. https:\/\/doi.org\/10.1097\/01.mlr.0000245426.10853.30","journal-title":"Med Care"},{"key":"13348_CR30","volume-title":"Applied factor analysis","author":"RJ Rummel","year":"1970","unstructured":"Rummel RJ, Rummel RJ (1970) Applied factor analysis. Northwestern University Press, Evanston"},{"key":"13348_CR31","volume-title":"Statistical theories of mental test scores","author":"FM Lord","year":"1968","unstructured":"Lord FM, Novick MR, Birnbaum A (1968) Statistical theories of mental test scores. Addison-Wesley, Oxford, England"},{"key":"13348_CR32","doi-asserted-by":"publisher","DOI":"10.4324\/9780203056615","volume-title":"Applications of Item Response Theory To Practical Testing Problems","author":"FM Lord","year":"2012","unstructured":"Lord FM (2012) Applications of Item Response Theory To Practical Testing Problems. Routledge, New York"},{"key":"13348_CR33","volume-title":"Probabilistic models for some intelligence and attainment tests","author":"G Rasch","year":"1980","unstructured":"Rasch G (1980) Probabilistic models for some intelligence and attainment tests. University of Chicago Press, Chicago"},{"key":"13348_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF02310555","volume":"16","author":"LJ Cronbach","year":"1951","unstructured":"Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297\u2013334. https:\/\/doi.org\/10.1007\/BF02310555","journal-title":"Psychometrika"},{"key":"13348_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1037\/1082-989X.1.1.30","volume":"1","author":"KO McGraw","year":"1996","unstructured":"McGraw KO, Wong SP (1996) Forming inferences about some intraclass correlation coefficients. Psychol Methods 1:30\u201346. https:\/\/doi.org\/10.1037\/1082-989X.1.1.30","journal-title":"Psychol Methods"},{"key":"13348_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF02289571","volume":"28","author":"W Kristof","year":"1963","unstructured":"Kristof W (1963) The statistical theory of stepped-up reliability coefficients when a test has been divided into several equivalent parts. Psychometrika 28:221\u2013238. https:\/\/doi.org\/10.1007\/BF02289571","journal-title":"Psychometrika"},{"key":"13348_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/BF02290603","volume":"34","author":"W Kristof","year":"1969","unstructured":"Kristof W (1969) Estimation of true score and error variance for tests under various equivalence assumptions. Psychometrika 34:489\u2013507. https:\/\/doi.org\/10.1007\/BF02290603","journal-title":"Psychometrika"},{"key":"13348_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2020.103632","volume":"108","author":"B-M Lindgren","year":"2020","unstructured":"Lindgren B-M, Lundman B, Graneheim UH (2020) Abstraction and interpretation during the qualitative content analysis process. Int J Nurs Stud 108:103632. https:\/\/doi.org\/10.1016\/j.ijnurstu.2020.103632","journal-title":"Int J Nurs Stud"},{"key":"13348_CR39","doi-asserted-by":"publisher","first-page":"160940692312057","DOI":"10.1177\/16094069231205789","volume":"22","author":"M Naeem","year":"2023","unstructured":"Naeem M, Ozuem W, Howell K, Ranfagni S (2023) A step-by-step process of thematic analysis to develop a conceptual model in qualitative research. Int J Qual Methods 22:16094069231205788. https:\/\/doi.org\/10.1177\/16094069231205789","journal-title":"Int J Qual Methods"},{"key":"13348_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10388","author":"NGA Spliethoff-Kamminga","year":"2003","unstructured":"Spliethoff-Kamminga NGA, Zwinderman AH, Springer MP, Roos RAC (2003) Psychosocial problems in Parkinson\u2019s disease: evaluation of a disease-specific questionnaire. Mov Disord. https:\/\/doi.org\/10.1002\/mds.10388","journal-title":"Mov Disord"},{"key":"13348_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40734-017-0059-x","volume":"4","author":"P Ortelli","year":"2017","unstructured":"Ortelli P, Maestri R, Zarucchi M et al (2017) Italian validation of the Belastungsfragebogen Parkinson kurzversion (BELA-P-k): a disease-specific questionnaire for evaluation of the subjective perception of quality of life in parkinson\u2019s disease. J Clin Mov Disord 4:12. https:\/\/doi.org\/10.1186\/s40734-017-0059-x","journal-title":"J Clin Mov Disord"},{"key":"13348_CR42","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/13814788.2021.2008352","volume":"27","author":"S Bayen","year":"2021","unstructured":"Bayen S, Heutte J, Vanderbecken J-C et al (2021) Translation and validation of two Parkinson\u2019s disease-specific burden questionnaires, for patients and caregivers, from German into French. EurJGenPract 27:364\u2013365. https:\/\/doi.org\/10.1080\/13814788.2021.2008352","journal-title":"EurJGenPract"},{"key":"13348_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25605","author":"R Aggarwal","year":"2013","unstructured":"Aggarwal R, Kumar N, Goyal V et al (2013) Development of health related quality of life instrument for Hindi speaking Parkinson\u2019s disease patients (indo-PDQOL) and initial psychometric testing. Mov Disord. https:\/\/doi.org\/10.1002\/mds.25605","journal-title":"Mov Disord"},{"key":"13348_CR44","doi-asserted-by":"publisher","first-page":"S403","DOI":"10.1016\/j.jval.2022.09.2006","volume":"25","author":"M Kuharic","year":"2022","unstructured":"Kuharic M, Shah K, Hanson K et al (2022) PCR71 off episode quality of life impact scale (OFFELIA): overview of the development of a quality of life and functional impact measure of off episodes in Parkinson\u2019s disease. Value Health 25:S403\u2013S404. https:\/\/doi.org\/10.1016\/j.jval.2022.09.2006","journal-title":"Value Health"},{"key":"13348_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106070","volume":"123","author":"M Kuharic","year":"2024","unstructured":"Kuharic M, Kulbokas V, Hanson K et al (2024) OFF episode quality of life impact scale (OFFELIA): a new measure of quality of life for off episodes in Parkinson\u2019s disease. Parkinsonism Relat Disord 123:106070. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106070","journal-title":"Parkinsonism Relat Disord"},{"key":"13348_CR46","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF02260863","volume":"4","author":"V Peto","year":"1995","unstructured":"Peto V, Jenkinson C, Fitzpatrick R, Greenhall R (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson\u2019s disease. Qual Life Res 4:241\u2013248. https:\/\/doi.org\/10.1007\/BF02260863","journal-title":"Qual Life Res"},{"key":"13348_CR47","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ageing\/26.5.353","volume":"26","author":"C Jenkinson","year":"1997","unstructured":"Jenkinson C, Fitzpatrick R, Peto V et al (1997) The Parkinson\u2019s Disease Questionnaire (PDQ-39): development and validation of a Parkinson\u2019s disease summary index score. Age Ageing 26:353\u2013357. https:\/\/doi.org\/10.1093\/ageing\/26.5.353","journal-title":"Age Ageing"},{"key":"13348_CR48","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/08870449708406741","volume":"12","author":"C Jenkinson","year":"1997","unstructured":"Jenkinson C, Fitzpatrick R, Greenhall R, Hyman N (1997) The PDQ-8: Development and validation of a short-term Parkinson\u2019s disease questionnaire. Pyschology and Health 12:805\u2013814","journal-title":"Pyschology and Health"},{"key":"13348_CR49","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1007\/PL00007737","volume":"245","author":"Mart\u00ednez-Mart\u00edn P, Payo BF, and The Grupo Centro for Study of Movement Disorders","year":"1998","unstructured":"Mart\u00ednez-Mart\u00edn P, Payo BF, and The Grupo Centro for Study of Movement Disorders (1998) Quality of life in Parkinson\u2019s disease: validation study of the PDQ-39 Spanish version. J Neurol 245:S34\u2013S38. https:\/\/doi.org\/10.1007\/PL00007737","journal-title":"J Neurol"},{"key":"13348_CR50","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1023\/A:1008979705027","volume":"8","author":"DM Bushnell","year":"1999","unstructured":"Bushnell DM, Martin ML (1999) Quality of life and Parkinson\u2019s disease: translation and validation of the US Parkinson\u2019s disease questionnaire (PDQ-39). Qual Life Res 8:345\u2013350","journal-title":"Qual Life Res"},{"key":"13348_CR51","volume-title":"The Parkinson\u2019s Disease Questionnaire (PDQ-39): Construct validity, reliability and patient-proxy respondent agreement of the French version department of epidemiology and biostatistics","author":"N Andreu","year":"2020","unstructured":"Andreu N (2020) The Parkinson\u2019s Disease Questionnaire (PDQ-39): Construct validity, reliability and patient-proxy respondent agreement of the French version department of epidemiology and biostatistics. McGill University, Montreal"},{"key":"13348_CR52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/jnnp.69.1.67","volume":"69","author":"A Schrag","year":"2000","unstructured":"Schrag A, Selai C, Jahanshahi M, Quinn NP (2000) The EQ-5D\u2014a generic quality of life measure\u2014is a useful instrument to measure quality of life in patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 69:67\u201373","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13348_CR53","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1023\/A:1016720400862","volume":"10","author":"Z Katsarou","year":"2001","unstructured":"Katsarou Z, Bostantjopoulou S, Peto V et al (2001) Quality of life in Parkinson\u2019s disease: Greek translation and validation of the Parkinson\u2019s disease questionnaire (PDQ-39). Qual Life Res 10:159\u2013163","journal-title":"Qual Life Res"},{"key":"13348_CR54","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/ageing\/30.4.299","volume":"30","author":"V Peto","year":"2001","unstructured":"Peto V (2001) Determining minimally important differences for the PDQ-39 Parkinson\u2019s disease questionnaire. Age Ageing 30:299\u2013302. https:\/\/doi.org\/10.1093\/ageing\/30.4.299","journal-title":"Age Ageing"},{"key":"13348_CR55","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/mds.10249","volume":"17","author":"K Tsang","year":"2002","unstructured":"Tsang K, Chi I, Ho S et al (2002) Translation and validation of the standard Chinese version of PDQ-39: a quality-of-life measure for patients with Parkinson\u2019s disease. Mov Disord 17:1036\u20131040. https:\/\/doi.org\/10.1002\/mds.10249","journal-title":"Mov Disord"},{"key":"13348_CR56","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/mds.10438","volume":"18","author":"P Hagell","year":"2003","unstructured":"Hagell P, Whalley D, McKenna SP, Lindvall O (2003) Health status measurement in Parkinson\u2019s disease: validity of the PDQ-39 and Nottingham health profile. Mov Disord 18:773\u2013783. https:\/\/doi.org\/10.1002\/mds.10438","journal-title":"Mov Disord"},{"key":"13348_CR57","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0895-4356(03)00148-3","volume":"56","author":"C Jenkinson","year":"2003","unstructured":"Jenkinson C, Fitzpatrick R, Norquist J et al (2003) Cross-cultural evaluation of the Parkinson\u2019s Disease Questionnaire: tests of data quality, score reliability, response rate, and scaling assumptions in the United States, Canada, Japan, Italy, and Spain. J Clin Epidemiol 56:843\u2013847. https:\/\/doi.org\/10.1016\/S0895-4356(03)00148-3","journal-title":"J Clin Epidemiol"},{"key":"13348_CR58","first-page":"1527","volume":"13","author":"HJ Park","year":"2004","unstructured":"Park HJ, Kim S, Song HJ et al (2004) Korean translation and validation of Parkinson\u2019s Disease Questionnaire (PDQ-39): a pilot test. Qual Life Res 13:1527","journal-title":"Qual Life Res"},{"key":"13348_CR59","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.parkreldis.2004.05.007","volume":"10","author":"LCS Tan","year":"2004","unstructured":"Tan LCS, Luo N, Nazri M et al (2004) Validity and reliability of the PDQ-39 and the PDQ-8 in English-speaking Parkinson\u2019s disease patients in Singapore. Parkinsonism Relat Disord 10:493\u2013499. https:\/\/doi.org\/10.1016\/j.parkreldis.2004.05.007","journal-title":"Parkinsonism Relat Disord"},{"key":"13348_CR60","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2003.07.003","volume":"57","author":"R Fitzpatrick","year":"2004","unstructured":"Fitzpatrick R, Norquist JM, Jenkinson C (2004) Distribution-based criteria for change in health-related quality of life in Parkinson\u2019s disease. J Clin Epidemiol 57:40\u201344. https:\/\/doi.org\/10.1016\/j.jclinepi.2003.07.003","journal-title":"J Clin Epidemiol"},{"key":"13348_CR61","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1136\/jnnp.2003.015693","volume":"75","author":"TH Haapaniemi","year":"2004","unstructured":"Haapaniemi TH (2004) The generic 15D instrument is valid and feasible for measuring health related quality of life in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 75:976\u2013983. https:\/\/doi.org\/10.1136\/jnnp.2003.015693","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13348_CR62","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.parkreldis.2005.02.003","volume":"11","author":"P Mart\u00ednez-Mart\u00edn","year":"2005","unstructured":"Mart\u00ednez-Mart\u00edn P, Serrano-Due\u00f1as M, Vaca-Baquero V (2005) Psychometric characteristics of the Parkinson\u2019s disease questionnaire (PDQ-39)\u2014ecuadorian version. Parkinsonism Relat Disord 11:297\u2013304. https:\/\/doi.org\/10.1016\/j.parkreldis.2005.02.003","journal-title":"Parkinsonism Relat Disord"},{"key":"13348_CR63","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11136-004-0687-0","volume":"14","author":"H-I Ma","year":"2005","unstructured":"Ma H-I, Hwang W-J, Chen-Sea M-J (2005) Reliability and validity testing of a Chinese-translated version of the 39-item Parkinson?s disease questionnaire (PDQ-39). Qual Life Res 14:565\u2013569. https:\/\/doi.org\/10.1007\/s11136-004-0687-0","journal-title":"Qual Life Res"},{"key":"13348_CR64","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11136-004-2654-1","volume":"14","author":"N Luo","year":"2005","unstructured":"Luo N, Tan LCS, Li SC et al (2005) Validity and reliability of the Chinese (Singapore) version of the Parkinson\u2019s Disease Questionnaire (PDQ-39). Qual Life Res 14:273\u2013279. https:\/\/doi.org\/10.1007\/s11136-004-2654-1","journal-title":"Qual Life Res"},{"key":"13348_CR65","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s11136-007-9224-2","volume":"16","author":"P Martinez-Martin","year":"2007","unstructured":"Martinez-Martin P, Serrano-Due\u00f1as M, Forjaz MJ, Serrano MS (2007) Two questionnaires for Parkinson\u2019s disease: are the PDQ-39 and PDQL equivalent? Qual Life Res 16:1221\u20131230. https:\/\/doi.org\/10.1007\/s11136-007-9224-2","journal-title":"Qual Life Res"},{"key":"13348_CR66","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1136\/jnnp.2006.111161","volume":"78","author":"P Hagell","year":"2007","unstructured":"Hagell P, Nygren C (2007) The 39 item Parkinson\u2019s disease questionnaire (PDQ-39) revisited: implications for evidence based medicine. J Neurol Neurosurg Psychiatry 78:1191\u20131198. https:\/\/doi.org\/10.1136\/jnnp.2006.111161","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13348_CR67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1477-7525-6-23","volume":"6","author":"\u00dc Krikmann","year":"2008","unstructured":"Krikmann \u00dc, Taba P, Lai T, Asser T (2008) Validation of an Estonian version of the Parkinson\u2019s Disease Questionnaire (PDQ-39). Health Qual Life Outcomes 6:23. https:\/\/doi.org\/10.1186\/1477-7525-6-23","journal-title":"Health Qual Life Outcomes"},{"key":"13348_CR68","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.parkreldis.2007.05.005","volume":"14","author":"J Marinus","year":"2008","unstructured":"Marinus J, Visser M, Jenkinson C, Stiggelbout AM (2008) Evaluation of the Dutch version of the Parkinson\u2019s disease questionnaire 39. Parkinsonism Relat Disord 14:24\u201327. https:\/\/doi.org\/10.1016\/j.parkreldis.2007.05.005","journal-title":"Parkinsonism Relat Disord"},{"key":"13348_CR69","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.parkreldis.2007.07.006","volume":"14","author":"M Serrano-Due\u00f1as","year":"2008","unstructured":"Serrano-Due\u00f1as M, Serrano S (2008) Psychometric characteristics of PIMS\u2014compared to PDQ-39 and PDQL\u2014to evaluate quality of life in Parkinson\u2019s disease patients: validation in Spanish (Ecuadorian style). Parkinsonism Relat Disord 14:126\u2013132. https:\/\/doi.org\/10.1016\/j.parkreldis.2007.07.006","journal-title":"Parkinsonism Relat Disord"},{"key":"13348_CR70","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s11136-009-9500-4","volume":"18","author":"L \u017diropa\u0111a","year":"2009","unstructured":"\u017diropa\u0111a L, Stefanova E, Potrebi\u0107 A, Kosti\u0107 VS (2009) Quality of life in Serbian patients with Parkinson\u2019s disease. Qual Life Res 18:833\u2013839. https:\/\/doi.org\/10.1007\/s11136-009-9500-4","journal-title":"Qual Life Res"},{"key":"13348_CR71","first-page":"63","volume":"15","author":"M Nojomi","year":"2010","unstructured":"Nojomi M, Mostafavian Z, Shahidi GA, Jenkinson C (2010) Quality of life in patients with Parkinson\u2019s disease: translation and psychometric evaluation of the Iranian version of PDQ-39. J Res Med Sci. 15:63","journal-title":"J Res Med Sci."},{"key":"13348_CR72","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1631\/jzus.B0900380","volume":"11","author":"W Luo","year":"2010","unstructured":"Luo W, Gui X, Wang B et al (2010) Validity and reliability testing of the Chinese (mainland) version of the 39-item Parkinson\u2019s disease questionnaire (PDQ-39). J Zhejiang Univ Sci B 11:531\u2013538. https:\/\/doi.org\/10.1631\/jzus.B0900380","journal-title":"J Zhejiang Univ Sci B"},{"key":"13348_CR73","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11136-010-9777-3","volume":"20","author":"T-T Huang","year":"2011","unstructured":"Huang T-T, Hsu H-Y, Wang B-H, Chen K-H (2011) Quality of life in Parkinson\u2019s disease patients: validation of the short-form eight-item Parkinson\u2019s disease questionnaire (PDQ-8) in Taiwan. Qual Life Res 20:499\u2013505. https:\/\/doi.org\/10.1007\/s11136-010-9777-3","journal-title":"Qual Life Res"},{"key":"13348_CR74","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s11136-011-0026-1","volume":"21","author":"J-L Zhang","year":"2012","unstructured":"Zhang J-L, Chan P (2012) Reliability and validity of PDQ-39: a quality-of-life measure for patients with PD in China. Qual Life Res 21:1217\u20131221. https:\/\/doi.org\/10.1007\/s11136-011-0026-1","journal-title":"Qual Life Res"},{"key":"13348_CR75","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3988\/jcn.2013.9.1.26","volume":"9","author":"D-Y Kwon","year":"2013","unstructured":"Kwon D-Y, Kim JW, Ma H-I et al (2013) Translation and validation of the Korean version of the 39-item Parkinson\u2019s disease questionnaire. J Clin Neurol 9:26. https:\/\/doi.org\/10.3988\/jcn.2013.9.1.26","journal-title":"J Clin Neurol"},{"key":"13348_CR76","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.anr.2014.02.004","volume":"8","author":"H-J Park","year":"2014","unstructured":"Park H-J, Sohng K-Y, Kim S (2014) Validation of the Korean version of the 39-item Parkinson\u2019s Disease Questionnaire (PDQ-39). Asian Nurs Res 8:67\u201374. https:\/\/doi.org\/10.1016\/j.anr.2014.02.004","journal-title":"Asian Nurs Res"},{"key":"13348_CR77","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1477-7525-12-78","volume":"12","author":"S-M Fereshtehnejad","year":"2014","unstructured":"Fereshtehnejad S-M, Naderi N, Rahmani A et al (2014) Psychometric study of the Persian short-form eight-item Parkinson\u2019s disease questionnaire (PDQ-8) to evaluate health related quality of life (HRQoL). Health Qual Life Outcomes 12:78. https:\/\/doi.org\/10.1186\/1477-7525-12-78","journal-title":"Health Qual Life Outcomes"},{"key":"13348_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26295","author":"A Krygowska-Wajs","year":"2015","unstructured":"Krygowska-Wajs A, Gorecka-Mazur A, Tomaszewski KA et al (2015) Psychometric validation of the Polish version Parkinson\u2019s disease questionnaire-39 (PDQ-39) and its short form (PDQ-8). Mov Disord. https:\/\/doi.org\/10.1002\/mds.26295","journal-title":"Mov Disord"},{"key":"13348_CR79","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12955-014-0193-1","volume":"13","author":"D Morley","year":"2015","unstructured":"Morley D, Dummett S, Kelly L et al (2015) Evaluating the psychometric properties of an e-based version of the 39-item Parkinson\u2019s Disease questionnaire. Health Qual Life Outcomes 13:5. https:\/\/doi.org\/10.1186\/s12955-014-0193-1","journal-title":"Health Qual Life Outcomes"},{"key":"13348_CR80","doi-asserted-by":"publisher","first-page":"A286","DOI":"10.1016\/j.jval.2015.03.1670","volume":"18","author":"D Morley","year":"2015","unstructured":"Morley D, Jenkinson C, Dummett S et al (2015) The Parkinson\u2019s disease questionnaire (Pdq-39) - evaluating the psychometric properties of an electronic version. Value Health 18:A286. https:\/\/doi.org\/10.1016\/j.jval.2015.03.1670","journal-title":"Value Health"},{"key":"13348_CR81","doi-asserted-by":"publisher","first-page":"395","DOI":"10.20344\/amp.8202","volume":"30","author":"J Jesus-Ribeiro","year":"2017","unstructured":"Jesus-Ribeiro J, Vieira E, Ferreira P et al (2017) Reliability and validity of 39-item Parkinson\u2019s Disease questionnaire and Parkinson\u2019s Disease quality of life questionnaire. Acta Med Port 30:395\u2013401. https:\/\/doi.org\/10.20344\/amp.8202","journal-title":"Acta Med Port"},{"key":"13348_CR82","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1007\/s10072-018-3524-x","volume":"39","author":"G Galeoto","year":"2018","unstructured":"Galeoto G, Colalelli F, Massai P et al (2018) Quality of life in Parkinson\u2019s disease: Italian validation of the Parkinson\u2019s Disease Questionnaire (PDQ-39-IT). Neurol Sci 39:1903\u20131909. https:\/\/doi.org\/10.1007\/s10072-018-3524-x","journal-title":"Neurol Sci"},{"key":"13348_CR83","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jocn.2018.06.013","volume":"54","author":"CTR Suratos","year":"2018","unstructured":"Suratos CTR, Saranza GRM, Sumalapao DEP, Jamora RDG (2018) Quality of life and Parkinson\u2019s disease: Philippine translation and validation of the Parkinson\u2019s disease questionnaire. J Clin Neurosci 54:156\u2013160. https:\/\/doi.org\/10.1016\/j.jocn.2018.06.013","journal-title":"J Clin Neurosci"},{"key":"13348_CR84","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.parkreldis.2019.06.018","volume":"65","author":"SK Holden","year":"2019","unstructured":"Holden SK, Koljack CE, Prizer LP et al (2019) Measuring quality of life in palliative care for Parkinson\u2019s disease: a clinimetric comparison. Parkinsonism Relat Disord 65:172\u2013177. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.06.018","journal-title":"Parkinsonism Relat Disord"},{"key":"13348_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7542138","volume":"2020","author":"G Nelson","year":"2020","unstructured":"Nelson G, Ndlovu N, Christofides N et al (2020) Validation of Parkinson\u2019s Disease-related questionnaires in South Africa. Parkinson\u2019s Disease 2020:1\u20139. https:\/\/doi.org\/10.1155\/2020\/7542138","journal-title":"Parkinson\u2019s Disease"},{"issue":"2","key":"13348_CR86","doi-asserted-by":"publisher","first-page":"147","DOI":"10.21032\/jhis.2020.45.2.147","volume":"45","author":"S Kim","year":"2020","unstructured":"Kim S, Park H-J, Park MJ, Kim HS (2020) Reliability and validity of the Korean short-form eight-item Parkinson\u2019s disease questionnaire (PDQ-8). J Health Info Stat 45(2):147\u2013156. https:\/\/doi.org\/10.21032\/jhis.2020.45.2.147","journal-title":"J Health Info Stat"},{"key":"13348_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105442","volume":"112","author":"A-M Hanff","year":"2023","unstructured":"Hanff A-M, McCrum C, Rauschenberger A et al (2023) Validation of a Parkinson\u2019s disease questionnaire-39-based functional mobility composite score (FMCS) in people with Parkinson\u2019s disease. Parkinsonism Relat Disord 112:105442. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105442","journal-title":"Parkinsonism Relat Disord"},{"key":"13348_CR88","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/mds.10678","volume":"19","author":"Z Katsarou","year":"2004","unstructured":"Katsarou Z, Bostantjopoulou S, Peto V et al (2004) Assessing quality of life in Parkinson\u2019s disease: can a short-form questionnaire be useful? Mov Disord 19:308\u2013312. https:\/\/doi.org\/10.1002\/mds.10678","journal-title":"Mov Disord"},{"key":"13348_CR89","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jns.2007.01.072","volume":"255","author":"LCS Tan","year":"2007","unstructured":"Tan LCS, Lau P-N, Au W-L, Luo N (2007) Validation of PDQ-8 as an independent instrument in English and Chinese. J Neurol Sci 255:77\u201380. https:\/\/doi.org\/10.1016\/j.jns.2007.01.072","journal-title":"J Neurol Sci"},{"key":"13348_CR90","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.parkreldis.2006.06.006","volume":"13","author":"C Jenkinson","year":"2007","unstructured":"Jenkinson C, Fitzpatrick R (2007) Cross-cultural evaluation of the short form 8-item Parkinson\u2019s Disease Questionnaire (PDQ-8): results from America, Canada, Japan, Italy and Spain. Parkinsonism Relat Disord 13:22\u201328. https:\/\/doi.org\/10.1016\/j.parkreldis.2006.06.006","journal-title":"Parkinsonism Relat Disord"},{"key":"13348_CR91","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11136-008-9341-6","volume":"17","author":"F Franchignoni","year":"2008","unstructured":"Franchignoni F, Giordano A, Ferriero G (2008) Rasch analysis of the short form 8-item Parkinson\u2019s Disease Questionnaire (PDQ-8). Qual Life Res 17:541\u2013548. https:\/\/doi.org\/10.1007\/s11136-008-9341-6","journal-title":"Qual Life Res"},{"key":"13348_CR92","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3138\/ptc.2009-08","volume":"63","author":"V Dal Bello-Haas","year":"2011","unstructured":"Dal Bello-Haas V, Klassen L, Sheppard MS, Metcalfe A (2011) Psychometric properties of activity, self-efficacy, and quality-of-life measures in individuals with Parkinson disease. Physiother Can 63:47\u201357. https:\/\/doi.org\/10.3138\/ptc.2009-08","journal-title":"Physiother Can"},{"key":"13348_CR93","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jns.2015.08.010","volume":"358","author":"A Alvarado-Bola\u00f1os","year":"2015","unstructured":"Alvarado-Bola\u00f1os A, Cervantes-Arriaga A, Rodr\u00edguez-Violante M et al (2015) Convergent validation of EQ-5D-5L in patients with Parkinson\u2019s disease. J Neurol Sci 358:53\u201357. https:\/\/doi.org\/10.1016\/j.jns.2015.08.010","journal-title":"J Neurol Sci"},{"key":"13348_CR94","doi-asserted-by":"publisher","DOI":"10.5152\/npa.2017.19343","author":"T Kahraman","year":"2017","unstructured":"Kahraman T, Genc A, Soke F et al (2017) Validity and reliability of the Turkish version of the 8-item Parkinson\u2019s Disease Questionnaire. Arch Neuropsychiatr. https:\/\/doi.org\/10.5152\/npa.2017.19343","journal-title":"Arch Neuropsychiatr"},{"key":"13348_CR95","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/08919887221119963","volume":"36","author":"Ramadhan M, Schrag A, and the CLaSP Consortium","year":"2023","unstructured":"Ramadhan M, Schrag A, and the CLaSP Consortium (2023) The validity of health-related quality of life instruments in patients with late-stage Parkinson\u2019s disease. J Geriatr Psychiatry Neurol 36:225\u2013232. https:\/\/doi.org\/10.1177\/08919887221119963","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"13348_CR96","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s41687-022-00427-0","volume":"6","author":"P Stathis","year":"2022","unstructured":"Stathis P, Papadopoulos G (2022) Evaluation and validation of a patient-reported quality-of-life questionnaire for Parkinson\u2019s disease. J Patient Rep Outcomes 6:17. https:\/\/doi.org\/10.1186\/s41687-022-00427-0","journal-title":"J Patient Rep Outcomes"},{"key":"13348_CR97","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2176\/nmc.oa.2020-0388","volume":"61","author":"M Kawaguchi","year":"2021","unstructured":"Kawaguchi M, Miyagi Y, Kishimoto J et al (2021) Development of quality of life questionnaire for patients with Parkinson\u2019s disease undergoing STN-DBS. Neurol Med Chir(Tokyo) 61:475\u2013483. https:\/\/doi.org\/10.2176\/nmc.oa.2020-0388","journal-title":"Neurol Med Chir(Tokyo)"},{"key":"13348_CR98","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/jnnp.61.1.70","volume":"61","author":"AG De Boer","year":"1996","unstructured":"De Boer AG, Wijker W, Speelman JD, De Haes JC (1996) Quality of life in patients with Parkinson\u2019s disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 61:70\u201374. https:\/\/doi.org\/10.1136\/jnnp.61.1.70","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13348_CR99","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.parkreldis.2004.05.002","volume":"10","author":"M Serrano-Duenas","year":"2004","unstructured":"Serrano-Duenas M, Mart\u0131nez-Mart\u0131n P, Vaca-Baquero V (2004) Validation and cross-cultural adjustment of PDQL-questionnaire, Spanish version (Ecuador) (PDQL-EV). Parkinson Relat Disord. 10:433\u2013437. https:\/\/doi.org\/10.1016\/j.parkreldis.2004.05.002","journal-title":"Parkinson Relat Disord."},{"key":"13348_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2011\/954787","volume":"2011","author":"M Campos","year":"2011","unstructured":"Campos M, Rezende CHAD, Farnese VDC et al (2011) Translation, cross-cultural adaptation, and validation of the Parkinson\u2019s disease quality of life questionnaire (PDQL), the \u201cPDQL-BR\u201d, into Brazilian Portuguese. ISRN Neurol 2011:1\u20135. https:\/\/doi.org\/10.5402\/2011\/954787","journal-title":"ISRN Neurol"},{"key":"13348_CR101","doi-asserted-by":"publisher","first-page":"128","DOI":"10.5152\/npa.2015.7359","volume":"52","author":"EE Dereli","year":"2015","unstructured":"Dereli EE, Yaliman A, Colaka TK et al (2015) Turkish Version Study of \u201cParkinson\u2019s Disease Quality of Life Questionnaire\u201d (PDQL). Arch Neuropsychiatr 52:128\u2013132. https:\/\/doi.org\/10.5152\/npa.2015.7359","journal-title":"Arch Neuropsychiatr"},{"key":"13348_CR102","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/mds.10424","volume":"18","author":"M Welsh","year":"2003","unstructured":"Welsh M, McDermott MP, Holloway RG et al (2003) Development and testing of the Parkinson\u2019s disease quality of life scale. Mov Disord 18:637\u2013645. https:\/\/doi.org\/10.1002\/mds.10424","journal-title":"Mov Disord"},{"key":"13348_CR103","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/1353-8020(95)00026-7","volume":"2","author":"S Calne","year":"1996","unstructured":"Calne S, Schulzer M, Mak E et al (1996) Validating a quality of life rating scale for idiopathic parkinsonism: Parkinson\u2019s impact scale (PIMS). Parkinsonism Relat Disord 2:55\u201361. https:\/\/doi.org\/10.1016\/1353-8020(95)00026-7","journal-title":"Parkinsonism Relat Disord"},{"key":"13348_CR104","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1353-8020(03)00019-1","volume":"9","author":"M Schulzer","year":"2003","unstructured":"Schulzer M, Mak E, Calne SM (2003) The psychometric properties of the Parkinson\u2019s impact scale (PIMS) as a measure of quality of life in Parkinson\u2019s disease. Parkinsonism Relat Disord 9:291\u2013294. https:\/\/doi.org\/10.1016\/S1353-8020(03)00019-1","journal-title":"Parkinsonism Relat Disord"},{"key":"13348_CR105","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4103\/aian.AIAN_471_18","volume":"23","author":"R Aggarwal","year":"2020","unstructured":"Aggarwal R, Goyal V, Pandey R et al (2020) Development and validation of quality of life in Parkinson\u2019s disease instrument. Ann Indian Acad Neurol 23:59. https:\/\/doi.org\/10.4103\/aian.AIAN_471_18","journal-title":"Ann Indian Acad Neurol"},{"key":"13348_CR106","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1136\/jnnp.74.8.1023","volume":"74","author":"A Kuehler","year":"2003","unstructured":"Kuehler A (2003) A novel quality of life instrument for deep brain stimulation in movement disorders. J Neurol Neurosurg Psychiatry 74:1023\u20131030. https:\/\/doi.org\/10.1136\/jnnp.74.8.1023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13348_CR107","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26295","author":"A Krygowska-Wajs","year":"2015","unstructured":"Krygowska-Wajs A, Tomaszewski KA, Gorecka-Mazur A et al (2015) Translation into Polish and validation of two quality of life assessment modules for patients with Parkinson\u2019s disease-QLSMMD and QLSM-DBS. Mov Disord. https:\/\/doi.org\/10.1002\/mds.26295","journal-title":"Mov Disord"},{"key":"13348_CR108","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/1545968318765497","volume":"32","author":"M Bose","year":"2018","unstructured":"Bose M, Bellare B, Parmar LD (2018) Development of health related quality of life questionnaire for people with parkinson\u2019s disease (PWP) in India. Neurorehabil Neural Repair 32:349\u2013350. https:\/\/doi.org\/10.1177\/1545968318765497","journal-title":"Neurorehabil Neural Repair"},{"key":"13348_CR109","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/1460-6984.12395","volume":"53","author":"JG Diniz","year":"2018","unstructured":"Diniz JG, Da Silva AC, N\u00f3brega AC (2018) Quality of life and swallowing questionnaire for individuals with Parkinson\u2019s disease: development and validation. Intl J Lang & Comm Disor 53:864\u2013874. https:\/\/doi.org\/10.1111\/1460-6984.12395","journal-title":"Intl J Lang & Comm Disor"},{"key":"13348_CR110","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s11136-013-0569-4","volume":"23","author":"M\u00c1 Garc\u00eda-Gordillo","year":"2014","unstructured":"Garc\u00eda-Gordillo M\u00c1, Del Pozo-Cruz B, Adsuar JC et al (2014) Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson\u2019s disease population sample. Qual Life Res 23:1315\u20131326. https:\/\/doi.org\/10.1007\/s11136-013-0569-4","journal-title":"Qual Life Res"},{"key":"13348_CR111","first-page":"233","volume":"36","author":"B Del Pozo-Cruz","year":"2018","unstructured":"Del Pozo-Cruz B, Collado-Mateo D, Adsuar JC et al (2018) A psychometric comparison of different health utility measures in patients affected by Parkinson\u2019s Disease. Nursing Economic 36:233\u2013244","journal-title":"Nursing Economic"},{"key":"13348_CR112","doi-asserted-by":"publisher","first-page":"521","DOI":"10.47102\/annals-acadmedsg.V38N6p521","volume":"38","author":"N Luo","year":"2009","unstructured":"Luo N, Low S, Lau P-N et al (2009) Is EQ5D a valid quality of life instrument in patients with Parkinson\u2019s Disease? A study in Singapore. Ann Acad Med Singap. 38:521\u2013528. https:\/\/doi.org\/10.47102\/annals-acadmedsg.V38N6p521","journal-title":"Ann Acad Med Singap."},{"key":"13348_CR113","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.3305\/nh.2015.32.6.9765","volume":"32","author":"M\u00c1 Garcia-Gordillo","year":"2015","unstructured":"Garcia-Gordillo M\u00c1, Del Pozo-Cruz B, Adsuar JC et al (2015) Validation and comparison of EQ-5D-3L and SF-6D instruments in a Spanish Parkinson \u0301s disease population sample. Nutr Hosp 32:2808\u20132821. https:\/\/doi.org\/10.3305\/nh.2015.32.6.9765","journal-title":"Nutr Hosp"},{"key":"13348_CR114","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22175","author":"CJ Nowinski","year":"2010","unstructured":"Nowinski CJ, Siderowf A, Victorson D et al (2010) Clinical validation of neuro-QOL measurement tools in Parkinson\u2019s disease. Annals of Neurology. https:\/\/doi.org\/10.1002\/ana.22175","journal-title":"Annals of Neurology"},{"key":"13348_CR115","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/mds.26546","volume":"31","author":"CJ Nowinski","year":"2016","unstructured":"Nowinski CJ, Siderowf A, Simuni T et al (2016) Neuro-qol health-related quality of life measurement system: validation in Parkinson\u2019s disease. Mov Disord 31:725\u2013733. https:\/\/doi.org\/10.1002\/mds.26546","journal-title":"Mov Disord"},{"key":"13348_CR116","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.parkreldis.2019.01.014","volume":"62","author":"A Kuspinar","year":"2019","unstructured":"Kuspinar A, Mate K, Lafontaine A-L, Mayo N (2019) Evaluating the content validity of generic preference-based measures for use in Parkinson\u2019s disease. Parkinsonism Relat Disord 62:112\u2013116. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.01.014","journal-title":"Parkinsonism Relat Disord"},{"key":"13348_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/6916135","volume":"2020","author":"A Kuspinar","year":"2020","unstructured":"Kuspinar A, Mate KKV, Lafontaine A-L, Mayo N (2020) Validation of an individualized measure of quality of life, patient generated index, for use with people with Parkinson\u2019s disease. Neurol Res Int 2020:1\u20138. https:\/\/doi.org\/10.1155\/2020\/6916135","journal-title":"Neurol Res Int"},{"key":"13348_CR118","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/JPD-2011-11026","volume":"1","author":"P Hagell","year":"2011","unstructured":"Hagell P, Westergren A (2011) Measurement properties of the SF-12 health survey in Parkinson\u2019s disease. J Parkinsons Dis 1:185\u2013196. https:\/\/doi.org\/10.3233\/JPD-2011-11026","journal-title":"J Parkinsons Dis"},{"key":"13348_CR119","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2522\/ptj.20070214","volume":"88","author":"T Steffen","year":"2008","unstructured":"Steffen T, Seney M (2008) Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item short-form health survey, and the unified Parkinson disease rating scale in people with Parkinsonism. Phys Ther 88:733\u2013746. https:\/\/doi.org\/10.2522\/ptj.20070214","journal-title":"Phys Ther"},{"key":"13348_CR120","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00415-008-0708-y","volume":"255","author":"P Hagell","year":"2008","unstructured":"Hagell P, T\u00f6rnqvist AL, Hobart J (2008) Testing the SF-36 in Parkinson\u2019s disease: implications for reporting rating scale data. J Neurol 255:246\u2013254. https:\/\/doi.org\/10.1007\/s00415-008-0708-y","journal-title":"J Neurol"},{"key":"13348_CR121","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/mds.22985","volume":"25","author":"CB Schneider","year":"2010","unstructured":"Schneider CB, Pilhatsch M, Rifati M et al (2010) Utility of the WHO-five well-being index as a screening tool for depression in Parkinson\u2019s disease. Mov Disord 25:777\u2013783. https:\/\/doi.org\/10.1002\/mds.22985","journal-title":"Mov Disord"},{"key":"13348_CR122","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1016\/j.apmr.2016.05.020","volume":"97","author":"SK Hendred","year":"2016","unstructured":"Hendred SK, Foster ER (2016) Use of the World Health Organization quality of life assessment short version in mild to moderate Parkinson disease. Arch Phys Med Rehabil 97:2123-2129.e1. https:\/\/doi.org\/10.1016\/j.apmr.2016.05.020","journal-title":"Arch Phys Med Rehabil"},{"key":"13348_CR123","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/mdc3.12874","volume":"7","author":"R Bou\u00e7a-Machado","year":"2020","unstructured":"Bou\u00e7a-Machado R, Duarte GS, Patriarca M et al (2020) Measurement instruments to assess functional mobility in Parkinson\u2019s disease: a systematic review. Mov Disord Clin Pract 7:129\u2013139. https:\/\/doi.org\/10.1002\/mdc3.12874","journal-title":"Mov Disord Clin Pract"},{"key":"13348_CR124","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.23072","volume":"25","author":"C Colosimo","year":"2010","unstructured":"Colosimo C, Mart\u00ednez-Mart\u00edn P, Fabbrini G et al (2010) Task force report on scales to assess dyskinesia in Parkinson\u2019s disease: critique and recommendations. Mov Disord 25:1131\u20131142. https:\/\/doi.org\/10.1002\/mds.23072","journal-title":"Mov Disord"},{"key":"13348_CR125","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s11136-011-0009-2","volume":"21","author":"RG Elbers","year":"2012","unstructured":"Elbers RG, Rietberg MB, Van Wegen EEH et al (2012) Self-report fatigue questionnaires in multiple sclerosis, Parkinson\u2019s disease and stroke: a systematic review of measurement properties. Qual Life Res 21:925\u2013944. https:\/\/doi.org\/10.1007\/s11136-011-0009-2","journal-title":"Qual Life Res"},{"key":"13348_CR126","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/mds.21875","volume":"23","author":"HH Fernandez","year":"2008","unstructured":"Fernandez HH, Aarsland D, F\u00e9nelon G et al (2008) Scales to assess psychosis in Parkinson\u2019s disease: critique and recommendations. Mov Disord 23:484\u2013500. https:\/\/doi.org\/10.1002\/mds.21875","journal-title":"Mov Disord"},{"key":"13348_CR127","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/mds.22989","volume":"25","author":"JH Friedman","year":"2010","unstructured":"Friedman JH, Alves G, Hagell P et al (2010) Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson\u2019s disease. Mov Disord 25:805\u2013822. https:\/\/doi.org\/10.1002\/mds.22989","journal-title":"Mov Disord"},{"key":"13348_CR128","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.sleep.2007.04.008","volume":"8","author":"B H\u00f6gl","year":"2007","unstructured":"H\u00f6gl B, Gschliesser V (2007) RLS assessment and sleep questionnaires in practice \u2013 lessons learned from Parkinson\u2019s disease. Sleep Med 8:S7\u2013S12. https:\/\/doi.org\/10.1016\/j.sleep.2007.04.008","journal-title":"Sleep Med"},{"key":"13348_CR129","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1002\/mds.23190","volume":"25","author":"B H\u00f6gl","year":"2010","unstructured":"H\u00f6gl B, Arnulf I, Comella C et al (2010) Scales to assess sleep impairment in Parkinson\u2019s disease: critique and recommendations. Mov Disord 25:2704\u20132716. https:\/\/doi.org\/10.1002\/mds.23190","journal-title":"Mov Disord"},{"key":"13348_CR130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217700","volume":"14","author":"VA Izzo","year":"2019","unstructured":"Izzo VA, Donati MA, Ramat S, Primi C (2019) Impulse control disorders in Parkinson\u2019s disease: a systematic review on the psychometric properties of the existing measures. PLoS ONE 14:e0217700. https:\/\/doi.org\/10.1371\/journal.pone.0217700","journal-title":"PLoS ONE"},{"key":"13348_CR131","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1002\/mds.23875","volume":"26","author":"A Antonini","year":"2011","unstructured":"Antonini A, Martinez-Martin P, Chaudhuri RK et al (2011) Wearing-off scales in Parkinson\u2019s disease: critique and recommendations. Mov Disord 26:2169\u20132175. https:\/\/doi.org\/10.1002\/mds.23875","journal-title":"Mov Disord"},{"key":"13348_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.945398","volume":"16","author":"R Bou\u00e7a-Machado","year":"2022","unstructured":"Bou\u00e7a-Machado R, Fernandes A, Ranzato C et al (2022) Measurement tools to assess activities of daily living in patients with Parkinson\u2019s disease: a systematic review. Front Neurosci 16:945398. https:\/\/doi.org\/10.3389\/fnins.2022.945398","journal-title":"Front Neurosci"},{"key":"13348_CR133","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/mds.22506","volume":"24","author":"J Kulisevsky","year":"2009","unstructured":"Kulisevsky J, Pagonabarraga J (2009) Cognitive impairment in Parkinson\u2019s disease: tools for diagnosis and assessment. Mov Disord 24:1103\u20131110. https:\/\/doi.org\/10.1002\/mds.22506","journal-title":"Mov Disord"},{"key":"13348_CR134","first-page":"307","volume":"22","author":"PJ O\u2019Connor","year":"1990","unstructured":"O\u2019Connor PJ (1990) Normative data: their definition, interpretation, and importance for primary care physicians. Fam Med 22:307\u2013311","journal-title":"Fam Med"},{"key":"13348_CR135","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","volume":"8","author":"D Wild","year":"2005","unstructured":"Wild D, Grove A, Martin M et al (2005) Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 8:94\u2013104. https:\/\/doi.org\/10.1111\/j.1524-4733.2005.04054.x","journal-title":"Value Health"},{"key":"13348_CR136","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/hex.12442","volume":"20","author":"B Wiering","year":"2017","unstructured":"Wiering B, de Boer D, Delnoij D (2017) Patient involvement in the development of patient-reported outcome measures: a scoping review. Health Expect 20:11\u201323. https:\/\/doi.org\/10.1111\/hex.12442","journal-title":"Health Expect"},{"key":"13348_CR137","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/hex.12459","volume":"20","author":"SJ Blackburn","year":"2017","unstructured":"Blackburn SJ (2017) Patient involvement vs. patient participation in qualitative research in the development of PROMs. Health Expect 20:371\u2013372. https:\/\/doi.org\/10.1111\/hex.12459","journal-title":"Health Expect"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13348-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13348-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13348-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:35:10Z","timestamp":1760524510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13348-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":137,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["13348"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13348-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest. All authors have reviewed and validated the final version of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"598"}}